US: 800.298.5699
Int'l: +1.240.747.3093
Matching geography
Reports matching your search in:
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!

Stem Cell Market Research Reports & Industry Analysis

Stem cells are unique in that they are undifferentiated cells that can differentiate to become virtually any type of cell in the body (totipotent). They therefore represent an ongoing source of the specialized cells that make up the tissues and organs. There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies.
Stem cells also have value as a research tool, as their in vitro study would allow scientists to learn more about the function of various organs and the development of particular diseases; stem cells may also eventually permit drug developers to test emerging therapies on diseased cells.

Cells must meet very specific criteria in order to be termed stem cells. They must: produce copies themselves; proliferate at a rapid rate; and display certain proteins on their surface that indicate a capacity to differentiate into other tissues, such as bone and cartilage. A stem cell line is a group of cells that all descend from a single original stem cell. Symmetric division gives rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division produces only one stem cell and a progenitor cell with limited self-renewal potential.

RSS Feeds

Stem Cell Industry Research & Market Reports

< prev 1    3  4  5  
Stem Cells Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Stem Cells in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 900
PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy
11/10/2014 | published by: GlobalData
... in various markets, recent deals activity and industry dynamic trends, as well as describes the operations strategy of these companies. Furthermore, it includes a geographical segmentation of various markets including the EU and US, as ...  |  read more...
USD 2,995
Stem Cell Therapeutics Markets (Cardiovascular and Circulatory Diseases, Endocrine Diseases, Digestive Disorders, Musculoskeletal, Nervous System, Cancer, Others)
10/9/2014 | published by: Kalorama Information
... new regenerative therapies. Stem cells have become effective tools in blood diseases, musculoskeletal diseases, digestive disorders and many other areas. Kalorama Information’s Stem Cell Therapeutics Markets conducts in-depth research into the stem cell market opportunity ...  |  read more...
USD 3,995
Cancer Stem Cells Drug Pipeline Update 2014
10/27/2014 | published by: BioSeeker Group AB
... development and cancer drugs which are inhibitors of the Hedgehog, Notch, and WNT Pathway. These developmental pathways are frequently activated in neoplasms, and particularly in the rare subpopulation of cancer stem cells. There are today ...  |  read more...
USD 6,746
Cell Expansion Market by Product (Reagent, Media, Serum, Bioreactors, Centrifuge), Cell Type (human, animal), Application (Stem Cell Research, Regenerative Medicine, Clinical Diagnostics), End User (Hospital, Biotechnology, Cell Bank) - Forecast to 2019
10/29/2014 | published by: MarketsandMarkets
... expansion market is expected to reach $14.8 billion by 2019 from $6.0 billion in 2014, growing at a CAGR of 19.7% from 2014 to 2019. The global cell expansion market is categorized on the basis ...  |  read more...
USD 4,650
Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2014
10/31/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Hematopoietic Stem Cell Transplantation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Complete 2015-16 Global Cord Blood Banking Industry Report.
11/1/2014 | published by: BioInformant Worldwide, L.L.C.
... increased the cost structure of cord blood banks A decline in cord blood transplants in 2013, within the U.S. and other geographical regions Low rates of turnover for stored cord blood units Expensive cord blood ...  |  read more...
USD 3,795
Plunkett's Biotech & Genetics Industry Almanac 2015: Biotech & Genetics Industry Market Research, Statistics, Trends & Leading Companies
10/25/2014 | published by: Plunkett Research, Ltd.
... trends analysis, market data and competitive intelligence Market forecasts and Industry Statistics Industry Associations and Professional Societies List In-Depth Profiles of hundreds of leading companies Industry Glossary Buyer may register for free access to search ...  |  read more...
USD 349.99
Plunkett's Biotech & Genetics Industry Trends & Statistics 2015: A Summary Version of Plunkett's Biotech & Genetics Industry Almanac 2015
10/25/2014 | published by: Plunkett Research, Ltd.
... 60 Statistical Tables Provided: 16 Geographic Focus: Global A condensed market research report excerpted from Plunkett’s Biotech & Genetics Industry Almanac 2015, including forecasts and market estimates, technologies analysis and vital statistical tables. You will ...  |  read more...
USD 199.99
Global and China Stem Cell Industry Report, 2014-2017
9/12/2014 | published by: Research in China
... be applied to treatment of cardiovascular diseases, leukemia (a kind of hematological system disease), nervous system diseases, damage or lesion of liver, kidney and other parenchymal organs, etc.. Currently, cord blood bank is the fastest-growing ...  |  read more...
USD 2,250
Analysis of the Global Stem Cell Market
10/7/2014 | published by: Frost & Sullivan
... of??% from 2013 to 2018. The worldwide market for adult stem cell is estimated to be at $??billion in 2013 and is projected to reach $?? billion by 2018. Adult stem cells constitute ??% of ...  |  read more...
USD 6,000
Stem Cells - Types, Technologies and Therapeutics
9/1/2014 | published by: RI Technologies
... are further classified into Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells and Other. Stem Cell Research by Technology is segmented into Stem Cell Transplantation, CB Genomics, Xenotransplantation, Cord Blood Banking and Other. ...  |  read more...
USD 8,100
Cell Isolation/Cell Separation Market by Product (Reagent, Media, Bead, centrifuge), Cell Type (human, stem cell, animal), Technique (Filtration, Surface Marker), Application (Research, IVD) & by End user (Hospital, Biotechnology) - Forecast to 2019
9/24/2014 | published by: MarketsandMarkets
... global cell isolation market is expected to reach $5.1 billion by 2019 from $2.5 billion in 2014, growing at a CAGR of 15.8% from 2014 to 2019. The global cell isolation market is categorized on ...  |  read more...
USD 4,650
The Global Market for Stem Cells
7/1/2014 | published by: BCC Research
... rate (CAGR) of 13.6% from 2013 through 2018. This report provides: An overview of the global market for stem cells and related technologies. Analyses of global market trends, with data from 2013, estimates for 2014, ...  |  read more...
USD 6,650
OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2018
8/20/2014 | published by: GlobalData
... cell transplants and the increasing use of biologic off-label and marketed therapies in the 6MM. Sanofi is a key player in the GVHD market with Thymoglobuline and Lemtrada by infiltrating prophylaxis, aGVHD and cGVHD. J&J’s ...  |  read more...
USD 7,995
EpiCast Report: Graft-Versus-Host Disease - Epidemiology Forecast to 2023
7/1/2014 | published by: GlobalData
... attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either acute GVHD (aGVHD) or chronic GVHD (cGVHD). Both aGVHD and cGVHD commonly affect organs such as the skin, gastrointestinal ...  |  read more...
USD 3,995
Regenerative Medicine Market in the US : 2014-2018
6/30/2014 | published by: TechNavio - Infiniti Research Ltd.
... Baxter International Inc., Johnson and Johnson Ltd., Kinetic Concepts Inc., Medtronic Inc., Stryker Corp., Aastrom Biosciences Inc., Acologix Inc., Advanced Cell Technology Inc., Arteriocyte Inc., Athersys Inc.,AvitaMedical Ltd., Bacterin International Inc., Bellicum Pharmaceuticals Inc., Bioactive ...  |  read more...
USD 3,000
Cell Therapy Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ...  |  read more...
USD 1,495
Stem Cell Research Market in India 2014
6/20/2014 | published by: Netscribes (India) Pvt. Ltd.
... various benefits it offers. Stem cells can be used to cure a number of diseases, including cancer and neurological disorders such as Parkinson’s disease, among others. The number of parents opting for stem cell storage ...  |  read more...
USD 950
Stem Cells - 6 Dimensional Assessment (Technical Insights)
6/27/2014 | published by: Frost & Sullivan
... potential to develop into many different cell types in the body during early life and growth. Indeed, under certain physiologic conditions they can be induced to become tissue or organ-specific cells with particular functions, thus ...  |  read more...
USD 6,500
Induced Pluripotent Stem Cells: Global Markets
6/1/2014 | published by: BCC Research
... market is expected to reach $2.9 billion in 2018, an estimated compound annual growth rate (CAGR) of 19.7% for the five-year period 2013 to 2018. This report provides: An overview of the global market for ...  |  read more...
USD 6,650
Research and Forecast on China Insulin Market, 2014-2018
4/15/2014 | published by: Huidian Research
... of China Insulin Market. A survey conducted by Huidian Research shows that China’s insulin market scale approximately registered CNY 11 billion in 2013, of which CNY 7.5 billion achieved in second-generation insulin market and CNY ...  |  read more...
USD 1,800
MediPoint: Bone Grafts and Substitutes - South American Analysis and Market Forecasts
1/31/2014 | published by: GlobalData
... has resulted in a gradual shift towards increased adoption of bone grafts and substitutes (BGS), especially in the US and European markets. In contrast to the general picture in developed countries, autograft bone still represents ...  |  read more...
USD 4,450
MediPoint: Bone Grafts and Substitutes - APAC Analysis and Market Forecasts
1/31/2014 | published by: GlobalData
... resulted in a gradual shift towards increased adoption of bone grafts and substitutes (BGS), especially in the US and European markets. In contrast to the general picture in developed countries, autograft bone still represents the ...  |  read more...
USD 4,450
High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics), by Apllications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industr
2/4/2014 | published by: MarketsandMarkets
... CRO) - Forecast to 2018 “Technological Advancements and Flourishing Outsourcing Industry Likely to Propel the Growth of the Global High Throughput Screening (HTS) Market” In this report, the global high throughput screening (HTS) market has ...  |  read more...
USD 4,650
< prev 1    3  4  5